NYSE: LLY - Eli Lilly and Company

Rentabilidade por seis meses: -6.27%
Rendimento de dividendos: +0.59%
Setor: Healthcare

Notícias

Eli Lilly cuts prices for Zepbound weight-loss drug again

3 marta 03:58 Eli Lilly cuts prices for Zepbound weight-loss drug again

Tony Bennett raised Alzheimer's funds, awareness

18 novembro 18:08 Tony Bennett raised Alzheimer's funds, awareness

Experts express concern over pharmaceutical giant Eli Lilly's new website connecting patients to obesity drugs

18 novembro 18:00 Experts express concern over pharmaceutical giant Eli Lilly's new website connecting patients to obesity drugs

Amazon Pharmacy will deliver Eli Lilly's Zepbound, other drugs to customers' doorsteps

18 novembro 17:44 Amazon Pharmacy will deliver Eli Lilly's Zepbound, other drugs to customers' doorsteps

Nestlé launches food line targeting Ozempic, other weight-loss drug users

18 novembro 17:12 Nestlé launches food line targeting Ozempic, other weight-loss drug users

25K Americans starting Wegovy weekly as supply increases and prices drop, drugmaker says

18 novembro 16:52 25K Americans starting Wegovy weekly as supply increases and prices drop, drugmaker says

Eli Lily's Mounjaro is more effective for weight loss than Ozempic, study shows

18 novembro 16:39 Eli Lily's Mounjaro is more effective for weight loss than Ozempic, study shows

Running low on Ozempic or another weight loss drug? A new tracker can help

18 novembro 16:30 Running low on Ozempic or another weight loss drug? A new tracker can help

Ozempic, Wegovy and other weight loss drugs present holiday challenges

18 novembro 16:29 Ozempic, Wegovy and other weight loss drugs present holiday challenges

What Is Ozempic and why is it such a big deal right now?

18 novembro 16:23 What Is Ozempic and why is it such a big deal right now?